683
Views
2
CrossRef citations to date
0
Altmetric
Letter

FDG PET/CT differentiating two malignant tumors in the same patient

, , , , &
Pages 142-144 | Received 30 Jun 2011, Accepted 07 Jul 2011, Published online: 18 Aug 2011

References

  • Lee B, Lim A, Lalvani A, Descamps MJ, Leonard R, Nallamala S, . The clinical significance of radiologically detected silent pulmonary nodules in early breast cancer. Ann Oncol 2008;19:2001–6.
  • Bar Shalom R, Kanga O, Israel O, Guralnik L. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-flouro-2deoxy-D-glucose avidity on positron emission tomography/computed tomography. Cancer 2008;113: 3213–21.
  • Spurrel EL, Fisher C, Thomas LM, Judson IR. Prognostic factors in advanced synovial sarcoma: An analysis of 104 patients treated at the Royal Marsden Hopsital. Ann Oncol 2005;16:437–44.
  • Essary LR, Vargas SO, Fletcher CD. Primary pleuropulmonary synovial sarcoma: Reappraisal of a recently described anatomic subset. Cancer 2002;94:459–69.
  • Charest M, Hickeson M, Lisbona R, Novales-Diaz JA, Derbekyan V, Turcotte RE. FDG PET/CT imaging in primary osseous and soft tissue sarcoma: A retrospective review of 212 cases. Eur J Nucl Med Mol Imaging 2009;36:1944–51.
  • Lisle JW, Eary JF, O'Sullivan J, Conard JU. Risk assessment based on FDG-PET in patients with synovial sarcoma. Clin Ortho Relat Res 2009;467:1605–11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.